Paper9635237
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
Jones RN. Diagn Microbiol Infect Dis, 1998. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes. Papers, record 9635237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9635237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Proteins | Major topic |
| Cephalosporins | Major topic |
| Enterobacteriaceae | Major topic |
| beta-Lactamases | Major topic |
| beta-Lactams | Major topic |
| Cross Infection | |
| Drug Resistance, Microbial | |
| Enterobacteriaceae Infections | |
| Enzyme Induction | |
| Humans |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38560541 | Cefepime Versus Piperacillin-Tazobactam for the Treatment of Intra-Abdominal Infections Secondary to Potential AmpC Beta-Lactamase-Producing Organisms. | Hosp Pharm | 2023 | https://conductscience.org/library/papers/38560541 | PubMed |
| 35631553 | Anti-Virulence Activity of 3,3'-Diindolylmethane (DIM): A Bioactive Cruciferous Phytochemical with Accelerated Wound Healing Benefits. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35631553 | PubMed |
| 34720161 | Comparison of Ceftriaxone and Antipseudomonal β-Lactam Antibiotics Utilized for Potential AmpC β-Lactamase-Producing Organisms. | Hosp Pharm | 2021 | https://conductscience.org/library/papers/34720161 | PubMed |
| 34199546 | Early Treatment Outcomes for Bloodstream Infections Caused by Potential AmpC Beta-Lactamase-Producing Enterobacterales with Focus on Piperacillin/Tazobactam: A Retrospective Cohort Study. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34199546 | PubMed |
| 32973731 | Characterization of a Novel Chromosomal Class C β-Lactamase, YOC-1, and Comparative Genomics Analysis of a Multidrug Resistance Plasmid in Yokenella regensburgei W13. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32973731 | PubMed |
| 31401649 | Molecular Epidemiology of Ceftriaxone Non-Susceptible Enterobacterales Isolates in an Academic Medical Center in the United States. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/31401649 | PubMed |
| 31363762 | Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/31363762 | PubMed |
| 30890721 | Comprehensive analysis of resistance-nodulation-cell division superfamily (RND) efflux pumps from Serratia marcescens, Db10. | Sci Rep | 2019 | https://conductscience.org/library/papers/30890721 | PubMed |
| 29405039 | A review of the use of pteridophytes for treating human ailments. | J Zhejiang Univ Sci B | 2018 | https://conductscience.org/library/papers/29405039 | PubMed |
| 24348054 | The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β-lactamase in Enterobacter cloacae. | Infect Drug Resist | 2013 | https://conductscience.org/library/papers/24348054 | PubMed |
| 23254646 | De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli. | Infection | 2013 | https://conductscience.org/library/papers/23254646 | PubMed |
| 22337978 | Concurrent occurrence of blaampC families and blaCTX-M genogroups and association with mobile genetic elements ISEcp1, IS26, ISCR1, and sul1-type class 1 integrons in Escherichia coli and Klebsiella pneumoniae isolates originating from India. | J Clin Microbiol | 2012 | https://conductscience.org/library/papers/22337978 | PubMed |
| 21747788 | Pseudomonas aeruginosa: resistance to the max. | Front Microbiol | 2011 | https://conductscience.org/library/papers/21747788 | PubMed |
| 19752278 | Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19752278 | PubMed |
| 19221354 | Antimicrobial resistance in hospitals: how concerned should we be? | CMAJ | 2009 | https://conductscience.org/library/papers/19221354 | PubMed |
| 18781358 | Characterization of a novel AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in China. | Curr Microbiol | 2008 | https://conductscience.org/library/papers/18781358 | PubMed |
| 17517839 | Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17517839 | PubMed |
| 16251324 | Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing beta-lactamase. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16251324 | PubMed |
| 15956430 | Gene mutations responsible for overexpression of AmpC beta-lactamase in some clinical isolates of Enterobacter cloacae. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/15956430 | PubMed |
| 15528723 | Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. | J Clin Microbiol | 2004 | https://conductscience.org/library/papers/15528723 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9635237
GET https://conductscience.org/api/papers/v1/9635237/cited_by?page=2